DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/5fr89r/european_cancer) has announced the addition of the "European Cancer Diagnostics Market 2013 - France, Germany, Italy, Spain, UK - Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering.
This comprehensive five-country report contains 820 pages, 320 tables, and presents analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years.
The report examines trends in major European countries (France, Germany, Italy, Spain, UK); reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease.
During the next five years, the European cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy.
Key Topics Covered:
II. Worldwide Market and Technology Overview
A. Cancer Statistics and Etiology
B. Major Current And Emerging Cancer Diagnostic Tests
C. Instrumentation Review And Market Needs
D. Current and Emerging Technologies
VIII. Major Product Development Opportunities
A. Reagent Kits and Test Systems/Panels
C. Computers, Software and Automation
D. Auxiliary Products
IX. Design Criteria for Decentralized Testing Products
X. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies
XI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XIV. Competitive Profiles
- Correlogic Systems/Vermillion
- Eiken Chemical
- Guided Therapeutics
- Kyowa Medex
- Life Technologies
- Myriad Genetics
- Nanogen Elitech
- Quest Diagnostics
- Siemens Healthcare
- Wako Pure Chemicals
For more information visit http://www.researchandmarkets.com/research/5fr89r/european_cancer